Cargando…

Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees

INTRODUCTION: We aimed to determine the incidence of SARS-CoV-2 infection among individuals with a previous SARS-CoV-2 infection versus vaccinated individuals. METHODS: In March 2020, a SARS-CoV-2 testing company began routinely screening its workforce for SARS-CoV-2 with a PCR test. On December 15,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kojima, N., Roshani, A., Brobeck, M., Baca, A., Klausner, J.D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828432/ https://www.ncbi.nlm.nih.gov/pubmed/35151852 http://dx.doi.org/10.1016/j.ijid.2022.02.015

Ejemplares similares

Vaccinated Individuals With Prior COVID-19 Have Lower Risk of Incident SARS-CoV-2 Infection When Compared With Vaccinated Individuals Without Prior Infection
por: Kojima, N, et al.
Publicado: (2022)

A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Protective immunity after recovery from SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022)

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
por: Kojima, N., et al.
Publicado: (2021)

SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals
por: Chellamuthu, Prithivi, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: anamnestic response in previously infected recipients
por: Purushotham, Jyothi N., et al.
Publicado: (2021)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers?
por: Pean De Ponfilly, G., et al.
Publicado: (2021)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
por: Nunes, Marta C., et al.
Publicado: (2022)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
por: Gupta, Aayush, et al.
Publicado: (2022)

Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
por: de Gier, Brechje, et al.
Publicado: (2023)

Duration of COVID-19 PCR positivity for Omicron vs earlier variants
por: Kojima, N., et al.
Publicado: (2022)

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
por: Maier, Hannah E., et al.
Publicado: (2022)

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department
por: Beck, Evan J., et al.
Publicado: (2022)

COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients
por: Shahid, Zainab, et al.
Publicado: (2023)

Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
por: Ekström, Nina, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
por: Wang, Jing, et al.
Publicado: (2023)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
por: Zhang, Xi-Ru, et al.
Publicado: (2023)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Delayed Kawasaki disease in an adult previously infected with SARS-CoV-2
por: Wang, Sheila, et al.
Publicado: (2022)

A Neuropsychiatric Assessment of Children with Previous SARS-CoV-2 Infection
por: Scarselli, Veronica, et al.
Publicado: (2023)

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
por: Konstantinidis, Theocharis G., et al.
Publicado: (2021)

Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID
por: Krishna, Benjamin A., et al.
Publicado: (2022)

Characteristics of SARS‐CoV‐2 positive individuals in California from two periods during notable decline in incident infection
por: Allan‐Blitz, Lao‐Tzu, et al.
Publicado: (2021)

Evaluation of the risk of SARS-CoV-2 infection and hospitalization in vaccinated and previously infected subjects based on real world data
por: Rossi, Maicol Andrea, et al.
Publicado: (2023)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

IMPACT OF VACCINATION AGAINST SARS-CoV-2 ON THE INCIDENCE OF INFECTION IN SCHOOL SETTINGS.
por: Diez, María Teresa Herrero, et al.
Publicado: (2023)

Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals
por: Boccuto, Adele, et al.
Publicado: (2021)

Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection
por: Patrignani, Anna, et al.
Publicado: (2021)

Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants
por: Ibarrondo, F. Javier, et al.
Publicado: (2021)

Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history
por: Ota, Kenji, et al.
Publicado: (2023)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bimva35dof7ufhl6icq2026qis